Upcoming Tocagen IPO To Finance Gene Therapy Clinical Trials

By: via Benzinga
The biotech firm Tocagen Inc. plans an Initial Public Offering to finance ongoing clinical trials of a technique that uses a weaponized ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.